| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 66.84 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 66.84. The average price that CVS shares were previous bought at was USD 62.9369. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 148,980 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 135.79 | USD -3,395 | The ETF sold 25 shares of DVA on 2025-06-18. The shares were previously bought for an average price of USD 152.874. The DaVita HealthCare Partners Inc shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 427 The average price that the ETF previously sold DVA share for is USD 153.27 which is higher than the selling price of USD 135.79 on 2025-06-18. |
| CRL - Creightons Plc | SELL | -28 @ USD 145.29 | USD -4,068 | The ETF sold 28 shares of CRL on 2025-06-18. The shares were previously bought for an average price of USD 166.268. The Creightons Plc shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 587 The average price that the ETF previously sold CRL share for is USD 186.789 which is higher than the selling price of USD 145.29 on 2025-06-18. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 50.13 | USD -4,361 | The ETF sold 87 shares of TECH on 2025-06-18. The shares were previously bought for an average price of USD 63.7706. The Bio-Techne Corp shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,187 The average price that the ETF previously sold TECH share for is USD 68.8208 which is higher than the selling price of USD 50.13 on 2025-06-18. |
| MRNA - Moderna Inc | SELL | -184 @ USD 25.4 | USD -4,674 | The ETF sold 184 shares of MRNA on 2025-06-18. The shares were previously bought for an average price of USD 34.3982. The Moderna Inc shares were sold for -26.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,656 The average price that the ETF previously sold MRNA share for is USD 40.4088 which is higher than the selling price of USD 25.4 on 2025-06-18. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 71.13 | USD -4,908 | The ETF sold 69 shares of HSIC on 2025-06-18. The shares were previously bought for an average price of USD 72.6037. The Henry Schein Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 102 The average price that the ETF previously sold HSIC share for is USD 71.7082 which is higher than the selling price of USD 71.13 on 2025-06-18. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 171.24 | USD -5,308 | The ETF sold 31 shares of UHS on 2025-06-18. The shares were previously bought for an average price of USD 187.054. The Universal Health Services Inc shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 490 The average price that the ETF previously sold UHS share for is USD 194.732 which is higher than the selling price of USD 171.24 on 2025-06-18. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 72.63 | USD -5,375 | The ETF sold 74 shares of SOLV on 2025-06-18. The shares were previously bought for an average price of USD 73.9731. The Solventum Corp. shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 99 The average price that the ETF previously sold SOLV share for is USD 71.5611 so the ETF has sold 74 shares on 2025-06-18 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -669 @ USD 8.77 | USD -5,867 | The ETF sold 669 shares of VTRS on 2025-06-18. The shares were previously bought for an average price of USD 10.2694. The Viatris Inc shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,003 The average price that the ETF previously sold VTRS share for is USD 11.806 which is higher than the selling price of USD 8.77 on 2025-06-18. |
| INCY - Incyte Corporation | SELL | -89 @ USD 68.27 | USD -6,076 | The ETF sold 89 shares of INCY on 2025-06-18. The shares were previously bought for an average price of USD 69.0887. The Incyte Corporation shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 73 The average price that the ETF previously sold INCY share for is USD 72.8235 which is higher than the selling price of USD 68.27 on 2025-06-18. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 94.41 | USD -6,420 | The ETF sold 68 shares of RVTY on 2025-06-18. The shares were previously bought for an average price of USD 110.61. The Revvity Inc. shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,102 The average price that the ETF previously sold RVTY share for is USD 112.895 which is higher than the selling price of USD 94.41 on 2025-06-18. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 180.01 | USD -7,020 | The ETF sold 39 shares of ALGN on 2025-06-18. The shares were previously bought for an average price of USD 188.339. The Align Technology Inc shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 325 The average price that the ETF previously sold ALGN share for is USD 214.069 which is higher than the selling price of USD 180.01 on 2025-06-18. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 69.81 | USD -7,819 | The ETF sold 112 shares of COO on 2025-06-18. The shares were previously bought for an average price of USD 87.3463. The The Cooper Companies, Inc. Common Stock shares were sold for -20.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,964 The average price that the ETF previously sold COO share for is USD 95.5757 which is higher than the selling price of USD 69.81 on 2025-06-18. |
| HOLX - Hologic Inc | SELL | -124 @ USD 63.97 | USD -7,932 | The ETF sold 124 shares of HOLX on 2025-06-18. The shares were previously bought for an average price of USD 66.77. The Hologic Inc shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 347 The average price that the ETF previously sold HOLX share for is USD 71.6014 which is higher than the selling price of USD 63.97 on 2025-06-18. |
| BAX - Baxter International Inc | SELL | -280 @ USD 29.8 | USD -8,344 | The ETF sold 280 shares of BAX on 2025-06-18. The shares were previously bought for an average price of USD 32.8808. The Baxter International Inc shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 863 The average price that the ETF previously sold BAX share for is USD 33.0559 which is higher than the selling price of USD 29.8 on 2025-06-18. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 217.95 | USD -8,500 | The ETF sold 39 shares of WST on 2025-06-18. The shares were previously bought for an average price of USD 255.435. The West Pharmaceutical Services Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,462 The average price that the ETF previously sold WST share for is USD 292.278 which is higher than the selling price of USD 217.95 on 2025-06-18. |
| MOH - MOH | SELL | -30 @ USD 295.34 | USD -8,860 | The ETF sold 30 shares of MOH on 2025-06-18. The shares were previously bought for an average price of USD 307.199. The MOH shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 356 The average price that the ETF previously sold MOH share for is USD 312.752 which is higher than the selling price of USD 295.34 on 2025-06-18. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 295.34 | USD -8,860 | The ETF sold 30 shares of MOH on 2025-06-18. The shares were previously bought for an average price of USD 307.199. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 356 The average price that the ETF previously sold MOH share for is USD 312.752 which is higher than the selling price of USD 295.34 on 2025-06-18. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 90.55 | USD -9,870 | The ETF sold 109 shares of ZBH on 2025-06-18. The shares were previously bought for an average price of USD 105.296. The Zimmer Biomet Holdings Inc shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,607 The average price that the ETF previously sold ZBH share for is USD 107.244 which is higher than the selling price of USD 90.55 on 2025-06-18. |
| BIIB - Biogen Inc | SELL | -80 @ USD 126.54 | USD -10,123 | The ETF sold 80 shares of BIIB on 2025-06-18. The shares were previously bought for an average price of USD 143.373. The Biogen Inc shares were sold for -11.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,347 The average price that the ETF previously sold BIIB share for is USD 156.689 which is higher than the selling price of USD 126.54 on 2025-06-18. |
| WAT - Waters Corporation | SELL | -32 @ USD 339.36 | USD -10,860 | The ETF sold 32 shares of WAT on 2025-06-18. The shares were previously bought for an average price of USD 367.564. The Waters Corporation shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 903 The average price that the ETF previously sold WAT share for is USD 371.508 which is higher than the selling price of USD 339.36 on 2025-06-18. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 339.36 | USD -10,860 | The ETF sold 32 shares of WAT on 2025-06-18. The shares were previously bought for an average price of USD 367.564. The MULETFWATIMETFP shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 903 The average price that the ETF previously sold WAT share for is USD 371.508 which is higher than the selling price of USD 339.36 on 2025-06-18. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 179.78 | USD -11,146 | The ETF sold 62 shares of DGX on 2025-06-18. The shares were previously bought for an average price of USD 167.721. The Quest Diagnostics Incorporated shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 748 The average price that the ETF previously sold DGX share for is USD 163.012 so the ETF has sold 62 shares on 2025-06-18 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -38 @ USD 301.79 | USD -11,468 | The ETF sold 38 shares of PODD on 2025-06-18. The shares were previously bought for an average price of USD 272.645. The Insulet Corporation shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 1,108 The average price that the ETF previously sold PODD share for is USD 267.812 so the ETF has sold 38 shares on 2025-06-18 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 261.39 | USD -11,763 | The ETF sold 45 shares of LH on 2025-06-18. The shares were previously bought for an average price of USD 243.365. The Laboratory Corporation of America Holdings shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 811 The average price that the ETF previously sold LH share for is USD 239.24 so the ETF has sold 45 shares on 2025-06-18 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1145.47 | USD -12,600 | The ETF sold 11 shares of MTD on 2025-06-18. The shares were previously bought for an average price of USD 1232.61. The Mettler-Toledo International Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 959 The average price that the ETF previously sold MTD share for is USD 1238.39 which is higher than the selling price of USD 1145.47 on 2025-06-18. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1145.47 | USD -12,600 | The ETF sold 11 shares of MTD on 2025-06-18. The shares were previously bought for an average price of USD 1232.61. The AMUNDI EUR GOV 710 shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 959 The average price that the ETF previously sold MTD share for is USD 1238.39 which is higher than the selling price of USD 1145.47 on 2025-06-18. |
| STE - STERIS plc | SELL | -55 @ USD 236.23 | USD -12,993 | The ETF sold 55 shares of STE on 2025-06-18. The shares were previously bought for an average price of USD 223.537. The STERIS plc shares were sold for 5.7% higher than average price of previous purchases. This sale made a profit of USD 698 The average price that the ETF previously sold STE share for is USD 220.756 so the ETF has sold 55 shares on 2025-06-18 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 154.61 | USD -14,224 | The ETF sold 92 shares of IQV on 2025-06-18. The shares were previously bought for an average price of USD 187.72. The IQVIA Holdings Inc shares were sold for -17.6% lower than average price of previous purchases. This resulted in an overall loss of USD 3,046 The average price that the ETF previously sold IQV share for is USD 194.452 which is higher than the selling price of USD 154.61 on 2025-06-18. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 55.15 | USD -15,221 | The ETF sold 276 shares of CNC on 2025-06-18. The shares were previously bought for an average price of USD 59.662. The Concurrent Technologies Plc shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,245 The average price that the ETF previously sold CNC share for is USD 59.6727 which is higher than the selling price of USD 55.15 on 2025-06-18. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 243.4 | USD -16,064 | The ETF sold 66 shares of HUM on 2025-06-18. The shares were previously bought for an average price of USD 267.361. The Hummingbird Resources PLC shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,581 The average price that the ETF previously sold HUM share for is USD 277.705 which is higher than the selling price of USD 243.4 on 2025-06-18. |
| HUM - Humana Inc | SELL | -66 @ USD 243.4 | USD -16,064 | The ETF sold 66 shares of HUM on 2025-06-18. The shares were previously bought for an average price of USD 267.361. The Humana Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,581 The average price that the ETF previously sold HUM share for is USD 277.705 which is higher than the selling price of USD 243.4 on 2025-06-18. |
| DXCM - DexCom Inc | SELL | -217 @ USD 81.01 | USD -17,579 | The ETF sold 217 shares of DXCM on 2025-06-18. The shares were previously bought for an average price of USD 78.5918. The DexCom Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 525 The average price that the ETF previously sold DXCM share for is USD 75.2868 so the ETF has sold 217 shares on 2025-06-18 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -251 @ USD 71.89 | USD -18,044 | The ETF sold 251 shares of GEHC on 2025-06-18. The shares were previously bought for an average price of USD 83.418. The GE HealthCare Technologies Inc. shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,894 The average price that the ETF previously sold GEHC share for is USD 81.1604 which is higher than the selling price of USD 71.89 on 2025-06-18. |
| A - Agilent Technologies Inc | SELL | -157 @ USD 115.52 | USD -18,137 | The ETF sold 157 shares of A on 2025-06-18. The shares were previously bought for an average price of USD 128.35. The Agilent Technologies Inc shares were sold for -10.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,014 The average price that the ETF previously sold A share for is USD 130.96 which is higher than the selling price of USD 115.52 on 2025-06-18. |
| RMD - ResMed Inc | SELL | -81 @ USD 250.88 | USD -20,321 | The ETF sold 81 shares of RMD on 2025-06-18. The shares were previously bought for an average price of USD 236.4. The ResMed Inc shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 1,173 The average price that the ETF previously sold RMD share for is USD 243.57 so the ETF has sold 81 shares on 2025-06-18 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -134 @ USD 165.4 | USD -22,164 | The ETF sold 134 shares of CAH on 2025-06-18. The shares were previously bought for an average price of USD 132.113. The Cardinal Health Inc shares were sold for 25.2% higher than average price of previous purchases. This sale made a profit of USD 4,460 The average price that the ETF previously sold CAH share for is USD 126.011 so the ETF has sold 134 shares on 2025-06-18 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 519.85 | USD -22,873 | The ETF sold 44 shares of IDXX on 2025-06-18. The shares were previously bought for an average price of USD 449.368. The IDEXX Laboratories Inc shares were sold for 15.7% higher than average price of previous purchases. This sale made a profit of USD 3,101 The average price that the ETF previously sold IDXX share for is USD 438.812 so the ETF has sold 44 shares on 2025-06-18 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -326 @ USD 73.98 | USD -24,117 | The ETF sold 326 shares of EW on 2025-06-18. The shares were previously bought for an average price of USD 71.411. The Edwards Lifesciences Corp shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 837 The average price that the ETF previously sold EW share for is USD 70.1423 so the ETF has sold 326 shares on 2025-06-18 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -159 @ USD 168.59 | USD -26,806 | The ETF sold 159 shares of BDX on 2025-06-18. The shares were previously bought for an average price of USD 220.617. The Becton Dickinson and Company shares were sold for -23.6% lower than average price of previous purchases. This resulted in an overall loss of USD 8,272 The average price that the ETF previously sold BDX share for is USD 218.918 which is higher than the selling price of USD 168.59 on 2025-06-18. |
| COR - Cencora Inc. | SELL | -95 @ USD 296.75 | USD -28,191 | The ETF sold 95 shares of COR on 2025-06-18. The shares were previously bought for an average price of USD 258.977. The Cencora Inc. shares were sold for 14.6% higher than average price of previous purchases. This sale made a profit of USD 3,588 The average price that the ETF previously sold COR share for is USD 253.135 so the ETF has sold 95 shares on 2025-06-18 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -58 @ USD 513.58 | USD -29,788 | The ETF sold 58 shares of REGN on 2025-06-18. The shares were previously bought for an average price of USD 682.385. The Regeneron Pharmaceuticals Inc shares were sold for -24.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,791 The average price that the ETF previously sold REGN share for is USD 741.954 which is higher than the selling price of USD 513.58 on 2025-06-18. |
| HCA - HCA Holdings Inc | SELL | -98 @ USD 376.86 | USD -36,932 | The ETF sold 98 shares of HCA on 2025-06-18. The shares were previously bought for an average price of USD 341.341. The HCA Holdings Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 3,481 The average price that the ETF previously sold HCA share for is USD 339.785 so the ETF has sold 98 shares on 2025-06-18 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -247 @ USD 155.06 | USD -38,300 | The ETF sold 247 shares of ZTS on 2025-06-18. The shares were previously bought for an average price of USD 166.535. The Zoetis Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,834 The average price that the ETF previously sold ZTS share for is USD 173.13 which is higher than the selling price of USD 155.06 on 2025-06-18. |
| CI - Cigna Corp | SELL | -151 @ USD 314.4 | USD -47,474 | The ETF sold 151 shares of CI on 2025-06-18. The shares were previously bought for an average price of USD 315.14. The Cigna Corp shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 112 The average price that the ETF previously sold CI share for is USD 321.698 which is higher than the selling price of USD 314.4 on 2025-06-18. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 375.91 | USD -47,741 | The ETF sold 127 shares of ELV on 2025-06-18. The shares were previously bought for an average price of USD 405.879. The Elevance Health Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,806 The average price that the ETF previously sold ELV share for is USD 408.395 which is higher than the selling price of USD 375.91 on 2025-06-18. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 375.91 | USD -47,741 | The ETF sold 127 shares of ELV on 2025-06-18. The shares were previously bought for an average price of USD 405.879. The Elevance Health Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,806 The average price that the ETF previously sold ELV share for is USD 408.395 which is higher than the selling price of USD 375.91 on 2025-06-18. |
| MCK - McKesson Corporation | SELL | -69 @ USD 728.91 | USD -50,295 | The ETF sold 69 shares of MCK on 2025-06-18. The shares were previously bought for an average price of USD 632.543. The McKesson Corporation shares were sold for 15.2% higher than average price of previous purchases. This sale made a profit of USD 6,649 The average price that the ETF previously sold MCK share for is USD 623.006 so the ETF has sold 69 shares on 2025-06-18 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,123 @ USD 46.84 | USD -52,601 | The ETF sold 1123 shares of BMY on 2025-06-18. The shares were previously bought for an average price of USD 56.1922. The Bloomsbury Publishing Plc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,503 The average price that the ETF previously sold BMY share for is USD 55.7888 which is higher than the selling price of USD 46.84 on 2025-06-18. |
| MDT - Medtronic PLC | SELL | -709 @ USD 85.73 | USD -60,783 | The ETF sold 709 shares of MDT on 2025-06-18. The shares were previously bought for an average price of USD 88.4281. The Medtronic PLC shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,913 The average price that the ETF previously sold MDT share for is USD 86.6089 which is higher than the selling price of USD 85.73 on 2025-06-18. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -141 @ USD 448.4 | USD -63,224 | The ETF sold 141 shares of VRTX on 2025-06-18. The shares were previously bought for an average price of USD 472.588. The Vertex Pharmaceuticals Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,411 The average price that the ETF previously sold VRTX share for is USD 476.141 which is higher than the selling price of USD 448.4 on 2025-06-18. |
| DHR - Danaher Corporation | SELL | -353 @ USD 194.44 | USD -68,637 | The ETF sold 353 shares of DHR on 2025-06-18. The shares were previously bought for an average price of USD 215.324. The Danaher Corporation shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,372 The average price that the ETF previously sold DHR share for is USD 229.044 which is higher than the selling price of USD 194.44 on 2025-06-18. |
| DHR - Danaher Corporation | SELL | -353 @ USD 194.44 | USD -68,637 | The ETF sold 353 shares of DHR on 2025-06-18. The shares were previously bought for an average price of USD 215.324. The Danaher Corporation shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,372 The average price that the ETF previously sold DHR share for is USD 229.044 which is higher than the selling price of USD 194.44 on 2025-06-18. |
| SYK - Stryker Corporation | SELL | -189 @ USD 373.26 | USD -70,546 | The ETF sold 189 shares of SYK on 2025-06-18. The shares were previously bought for an average price of USD 379.416. The Stryker Corporation shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,163 The average price that the ETF previously sold SYK share for is USD 379.085 which is higher than the selling price of USD 373.26 on 2025-06-18. |
| GILD - Guild Esports Plc | SELL | -689 @ USD 108 | USD -74,412 | The ETF sold 689 shares of GILD on 2025-06-18. The shares were previously bought for an average price of USD 103.187. The Guild Esports Plc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 3,316 The average price that the ETF previously sold GILD share for is USD 96.166 so the ETF has sold 689 shares on 2025-06-18 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,134 @ USD 23.88 | USD -74,840 | The ETF sold 3134 shares of PFE on 2025-06-18. The shares were previously bought for an average price of USD 25.6134. The Pfizer Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,432 The average price that the ETF previously sold PFE share for is USD 25.6142 which is higher than the selling price of USD 23.88 on 2025-06-18. |
| BSX - Boston Scientific Corporation | SELL | -814 @ USD 101.37 | USD -82,515 | The ETF sold 814 shares of BSX on 2025-06-18. The shares were previously bought for an average price of USD 99.0817. The Boston Scientific Corporation shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,863 The average price that the ETF previously sold BSX share for is USD 91.645 so the ETF has sold 814 shares on 2025-06-18 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -814 @ USD 101.37 | USD -82,515 | The ETF sold 814 shares of BSX on 2025-06-18. The shares were previously bought for an average price of USD 99.0817. The MULSTRXSSXIMETFP shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,863 The average price that the ETF previously sold BSX share for is USD 91.645 so the ETF has sold 814 shares on 2025-06-18 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -211 @ USD 392.56 | USD -82,830 | The ETF sold 211 shares of TMO on 2025-06-18. The shares were previously bought for an average price of USD 509.07. The Time Out Group plc shares were sold for -22.9% lower than average price of previous purchases. This resulted in an overall loss of USD 24,584 The average price that the ETF previously sold TMO share for is USD 512.711 which is higher than the selling price of USD 392.56 on 2025-06-18. |
| AMGN - Amgen Inc | SELL | -296 @ USD 289.63 | USD -85,730 | The ETF sold 296 shares of AMGN on 2025-06-18. The shares were previously bought for an average price of USD 300.673. The Amgen Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,269 The average price that the ETF previously sold AMGN share for is USD 295.491 which is higher than the selling price of USD 289.63 on 2025-06-18. |
| ISRG - Intuitive Surgical Inc | SELL | -196 @ USD 509.49 | USD -99,860 | The ETF sold 196 shares of ISRG on 2025-06-18. The shares were previously bought for an average price of USD 540.404. The Intuitive Surgical Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,059 The average price that the ETF previously sold ISRG share for is USD 532.347 which is higher than the selling price of USD 509.49 on 2025-06-18. |
| MRK - Marks Electrical Group PLC | SELL | -1,399 @ USD 79.29 | USD -110,927 | The ETF sold 1399 shares of MRK on 2025-06-18. The shares were previously bought for an average price of USD 90.4995. The Marks Electrical Group PLC shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 15,682 The average price that the ETF previously sold MRK share for is USD 96.9046 which is higher than the selling price of USD 79.29 on 2025-06-18. |
| MRK - Merck & Company Inc | SELL | -1,399 @ USD 79.29 | USD -110,927 | The ETF sold 1399 shares of MRK on 2025-06-18. The shares were previously bought for an average price of USD 90.4995. The Merck & Company Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 15,682 The average price that the ETF previously sold MRK share for is USD 96.9046 which is higher than the selling price of USD 79.29 on 2025-06-18. |
| ABT - Abbott Laboratories | SELL | -959 @ USD 132.41 | USD -126,981 | The ETF sold 959 shares of ABT on 2025-06-18. The shares were previously bought for an average price of USD 127.282. The Abbott Laboratories shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 4,918 The average price that the ETF previously sold ABT share for is USD 120.041 so the ETF has sold 959 shares on 2025-06-18 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -507 @ USD 307.2 | USD -155,750 | The ETF sold 507 shares of UNH on 2025-06-18. The shares were previously bought for an average price of USD 500.135. The UnitedHealth Group Incorporated shares were sold for -38.6% lower than average price of previous purchases. This resulted in an overall loss of USD 97,818 The average price that the ETF previously sold UNH share for is USD 548.504 which is higher than the selling price of USD 307.2 on 2025-06-18. |
| ABBV - AbbVie Inc | SELL | -972 @ USD 185.49 | USD -180,296 | The ETF sold 972 shares of ABBV on 2025-06-18. The shares were previously bought for an average price of USD 191.768. The AbbVie Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,102 The average price that the ETF previously sold ABBV share for is USD 186.487 which is higher than the selling price of USD 185.49 on 2025-06-18. |
| JNJ - Johnson & Johnson | SELL | -1,323 @ USD 150.73 | USD -199,416 | The ETF sold 1323 shares of JNJ on 2025-06-18. The shares were previously bought for an average price of USD 156.901. The Johnson & Johnson shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 8,164 The average price that the ETF previously sold JNJ share for is USD 154.592 which is higher than the selling price of USD 150.73 on 2025-06-18. |
| LLY - Eli Lilly and Company | SELL | -430 @ USD 785.03 | USD -337,563 | The ETF sold 430 shares of LLY on 2025-06-18. The shares were previously bought for an average price of USD 829.519. The Eli Lilly and Company shares were sold for -5.4% lower than average price of previous purchases. This resulted in an overall loss of USD 19,130 The average price that the ETF previously sold LLY share for is USD 796.749 which is higher than the selling price of USD 785.03 on 2025-06-18. |